Specificity of interferon action in protein synthesis.
Inhibitors of elongation steps in protein synthesis such as cycloheximide and anisomycin mimic interferon treatment in that they specifically inhibit the synthesis of certain viral proteins. These specific effects are seen only at very low concentrations of the antibiotics, under conditions where host cellular protein synthesis, as well as cell viability, are not severely reduced. A qualitatively as well as quantitatively close correlation between the effects of the two types of agents has been established for encephalomyocarditis virus, vesicular stomatitis virus and murine leukemia virus protein synthesis. It is concluded that one of the primary mechanisms of interferon action may be a nonspecific retardation of one or more elongation steps, and that this may be sufficient to account for its effects on the replication of certain viruses such as encephalomyocarditis and vesicular stomatitis viruses.
D000841:Anisomycin / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D004686:Encephalomyocarditis virus / Q000378:metabolism*; D007372:Interferons / Q000494:pharmacology*; D007739:L Cells; D009052:Leukemia Virus, Murine / Q000378:metabolism; D010142:Pactamycin / Q000494:pharmacology; D010441:Peptide Chain Elongation, Translational / Q000187:drug effects*; D014176:Protein Biosynthesis / Q000187:drug effects; D014721:Vesicular stomatitis Indiana virus / Q000378:metabolism*; D014764:Viral Proteins / Q000096:biosynthesis*
D014764:Viral Proteins; D010142:Pactamycin; D000841:Anisomycin; D007372:Interferons; D003513:Cycloheximide